Introduction
Patients and methods
Patients
Study Design and Laboratory assays
Histological analysis
Statistical analysis
Results
Clinical and biochemical analysis
GENOTYPE 1
(N = 93)
|
GENOTYPE NON-1
(N = 45)
| P | |
---|---|---|---|
Age | 54.06 | 51.59 | 0.14 |
Fasting Glucose | 92.58 | 100.13 | 0.80 |
Homocysteine* (μmol/L)
| 9.96 | 9.39 |
0.01*
|
HOMA | 2.72 | 3.35 | 0.74 |
AST (UI) | 68.69 | 73.24 | 0.97 |
ALT(UI) | 84.02 | 91.56 | 0.58 |
γGT(UI) | 86.06 | 84.31 | 0.93 |
AP(UI) | 83.03 | 72.67 | 0.26 |
Total Cholesterol*(mg/dL)
| 158.01 | 138.58 |
0.01*
|
HDL (mg/dL) | 49.05 | 46.73 | 0.29 |
LDL(mg/dL) | 88.00 | 74.44 | 0.10 |
Triglycerides (mg/dL)
| 105.89 | 91.69 | 0.05* |
Homocysteine
Media ± SD
| p | |
---|---|---|
Fibrosis 1+2 (n = 105)
| 9.7 ± 4.7 | |
Fibrosis 3+4 (n = 40)
| 10.4 ± 2.9 | 0.30 |
No Steatosis (n = 46)
| 9.0 ± 2.8 | |
Steatosis (n = 99)
| 10.3 ± 4.8 |
0.03*
|
Genotype 1 (n = 96)
| 10.1 ± 2.9 | |
Genotype Non -1 (n = 49)
| 9.5 ± 6.1 | 0.55 |
Variables
|
CT+TT
Media ± SD (n = 65)
|
CC
Media ± SD (n = 73)
|
p
|
---|---|---|---|
Total Cholesterol
| 147.3 ± 33.7 | 155.6 ± 43.8 | 0.21 |
HDL
| 47.5 ± 14.4 | 49.0 ± 13.9 | 0.55 |
LDL
| 79.7 ± 30.4 | 87.0 ± 39.8 | 0.23 |
Triglyceride
| 103.4 ± 40.6 | 99.4 ± 45.9 | 0.59 |
Fasting Glucose
| 97.4 ± 37.5 | 93.0 ± 18.1 | 0.39 |
Folate
| 12.9 ± 2.8 | 12.4 ± 2.8 | 0.33 |
Vit.B12
| 766.7 ± 361.8 | 652.8 ± 278.3 | 0.09 |
HOMA
| 3.2 ± 2.9 | 2.7 ± 1.8 | 0.21 |
Homocysteine
| 10.2 ± 5.4 | 9.5 ± 2.8 | 0.31 |
MTHFR677C/T polymorphism
Genotype frequencies (%)
| ||||
---|---|---|---|---|
MTHFR
| TT | CT | CC | p |
Steatosis (n = 104)
| 5.7 | 40.4 | 53.8 | 0.80 |
No Steatosis (n = 70)
| 7.1 | 41.4 | 51.4 | |
Fibrosis 1+2 (n = 116)
| 5.1 | 37.9 | 56.9 | 0.21 |
Fibrosis 3+4 (n = 58)
| 8.6 | 46.5 | 44.8 | |
Genotype 1 (n = 113)
| 4.4 | 35.4 | 60.1 |
0.01*
|
Genotype Non-1 (n = 61)
| 9.8 | 50.8 | 39.3 |
MTHFR
|
Genotype 1
Genotype frequencies (%)
|
p
|
Genotype non 1
Genotype frequencies (%)
|
p
| ||
---|---|---|---|---|---|---|
CT+TT | CC | CT+TT | CC | |||
Fibrosis 1+2
| 37 (48.7%) | 39 (51.3%) | 0.43 | 19 (47.5%) | 21 (52.5%) | 0.80 |
Fibrosis 3+4
| 15 (40.5%) | 22 (59.5%) | 11 (52.4%) | 10 (47.6%) | ||
No Steatosis
| 23 (48.9%) | 24 (51.1%) | 0.70 | 08 (34.8%) | 15 (65.2%) | 0.11 |
Steatosis
| 29 (43.9%) | 37 (56.1%) | 22 (57.9%) | 16 (42.1%) |
MTHFR
TT+CT (%)
|
p
| |
---|---|---|
Fibrosis 1+2 (n = 116) | 68.3 | |
Fibrosis 3+4 (n = 58) | 31.7 |
0.001*
|
No Steatosis (n = 70) | 37.8 | |
Steatosis (n = 104) | 62.8 |
0.04*
|
Variables
|
OR (CI 95%)
|
p*
|
OR adjusted
|
p
|
OR adjusted
|
p
|
---|---|---|---|---|---|---|
Gender: F/M | 1.1 (0.6-2.0) | 0.88 | 1.1(0.5-2.3) | 0.90 | 1.1 (0.5-2.3) | 0.87 |
HOMA ≥ 2.5 | 1.5 (0.7-3.2) | 0.35 | 1.3 (0.6-2.9) | 0.40 | 1.4 (0.7-3.1) | 0.35 |
LDL cholesterol ≥ 130 | 0.5 (0.2-1.6) | 0.35 | 0.6 (0.2-1.9) | 0.35 | - (**) | - |
HDL cholesterol ≤ 40 | 1.1 (0.5-2.4) | 0.84 | 0.9 (0.4-2.1) | 0.82 | 1.0 (0.4-2.2) | 0.93 |
Total Cholesterol ≥ 200 | 0.8 (0.2-2.9) | 0.75 | - (**) | - | 0.9 (0.2-3.6) | 0.96 |
Triglyceride ≥ 150 | 0.6 (0.2-1.8) | 0.38 | 0.6 (0.2-1.9) | 0.40 | 0.6 (0.2-1.9) | 0.37 |
TT+CT (MTHFR) | 0.8 (0.4-1.5) | 0.64 | 1.0 (0.5-2.1) | 0.94 | 1.0 (0.5-2.1) | 0.95 |
Homocysteine ≥ 9 | 1.6 (0.8-3.3) | 0.18 | 1.6 (0.7-3.3) | 0.24 | 1.6 (0.7-3.3) | 0.25 |
Variables
|
OR (CI 95%)
|
p*
|
OR adjusted
|
p
|
OR adjusted
|
p
|
---|---|---|---|---|---|---|
Gender: F/M | 0.9 (0.5-1.7) | 0.87 | 1.1 (0.5-2.4) | 0.85 | 1.1 (0.5-2.4) | 0.82 |
HOM- ≥ 2.5 | 0.8 (0.4-1.8) | 0.55 | 0.8 (0.4-1.8) | 0.63 | 0.8 (0.4-1.8) | 0.57 |
LDL cholesterol ≥ 130 | 2.1 (0.4-10) | 0.51 | 2.2 (0.4-11.1) | 0.34 | -(**) | - |
HDL cholesterol ≤ 40 | 1.0 (0.4-2.3) | 1.00 | 1.3 (0.6-3.2) | 0.51 | 1.3 (0.5-3.2) | 0.53 |
Tot-l Cholesterol ≥ 200 | 1.7 (0.3-8.3) | 0.73 | -(**) | - | 1.8 (0.3-9.2) | 0.49 |
Triglyceride ≥ 150 | 1.4 (0.4-5.3) | 0.76 | 1.3 (0.3-5.0) | 0.70 | 1.3 (0.3-5.1) | 0.72 |
TT+CT (MTHFR) | 0.9 (0.5-1.7) | 0.75 | 1.4 (0.7-3.1) | 0.39 | 1.4 (0.6-3.1) | 0.39 |
Homocysteine ≥ 9 | 0.6 (0.3-1.3) | 0.17 | 0.7(0.3-1.5) | 0.34 | 0.7 (0.3-1.5) | 0.35 |